This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Allen Maycock, C. A. Search for Related Content PubMed PubMed Citation Articles by Allen Maycock, C. A.

Statin therapy is associated with reduced mortality across all age groups of individuals with significant coronary disease, including very elderly patients

Chloe A. Allen Maycock, RN, BSN^*, Joseph B. Muhlestein, MD, FACC^*,*, Benjamin D. Horne, MPH^*, John F. Carlquist, PhD^*, Tami L. Bair, BS^*, Robert R. Pearson, BS^*, Qunyu Li, MD^*, Jeffrey L. Anderson, MD, FACC^* Intermountain Heart Collaborative Study

^* LDS Hospital, Salt Lake City, Utah, USA
University of Utah, Salt Lake City, Utah, USA

View larger version (20K): [in a new window]   Figure 1 Bar graph of mortality for patients using statins (open bars) and not using statins (solid bars) by age groups.

View larger version (35K): [in a new window]   Figure 2 Univariate Kaplan-Meier survival curves for statin users and nonusers among three age groups: (A) younger patients <65 years old; (B) older patients 65 to 79 years old; and (C) very elderly patients 80 years of age or older. Continued on next page.

View larger version (36K): [in a new window]   Figure 3 Multivariate adjusted Kaplan-Meier survival curves for statin users and nonusers among the age groups: (A) younger patients <65 years old; (B) older patients 65 to 79 years old; and (C) very elderly patients 80 years of age or older. Although the absolute survival rates differed substantially across the age groups, statins had clinically profound benefits for all age groups of patients with coronary artery disease. HR = hazard ratio. Continued on next page.